These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 34965151)
1. Reverse phase protein arrays in acute leukemia: investigative and methodological challenges. Hoff FW; Horton TM; Kornblau SM Expert Rev Proteomics; 2021 Dec; 18(12):1087-1097. PubMed ID: 34965151 [TBL] [Abstract][Full Text] [Related]
2. The effects of sample handling on proteomics assessed by reverse phase protein arrays (RPPA): Functional proteomic profiling in leukemia. Horton TM; Hoff FW; van Dijk A; Jenkins GN; Morrison D; Bhatla T; Hogan L; Romanos-Sirakis E; Meyer J; Carroll WL; Qiu Y; Wang T; Mo Q; Kornblau SM J Proteomics; 2021 Feb; 233():104046. PubMed ID: 33212251 [TBL] [Abstract][Full Text] [Related]
3. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Tibes R; Qiu Y; Lu Y; Hennessy B; Andreeff M; Mills GB; Kornblau SM Mol Cancer Ther; 2006 Oct; 5(10):2512-21. PubMed ID: 17041095 [TBL] [Abstract][Full Text] [Related]
4. Use of reverse phase protein microarrays to study protein expression in leukemia: technical and methodological lessons learned. Kornblau SM; Coombes KR Methods Mol Biol; 2011; 785():141-55. PubMed ID: 21901598 [TBL] [Abstract][Full Text] [Related]
5. Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society. Akbani R; Becker KF; Carragher N; Goldstein T; de Koning L; Korf U; Liotta L; Mills GB; Nishizuka SS; Pawlak M; Petricoin EF; Pollard HB; Serrels B; Zhu J Mol Cell Proteomics; 2014 Jul; 13(7):1625-43. PubMed ID: 24777629 [TBL] [Abstract][Full Text] [Related]
6. Reverse-Phase Protein Array: Technology, Application, Data Processing, and Integration. Coarfa C; Grimm SL; Rajapakshe K; Perera D; Lu HY; Wang X; Christensen KR; Mo Q; Edwards DP; Huang S J Biomol Tech; 2021 Apr; 32(1):15-29. PubMed ID: 34025221 [TBL] [Abstract][Full Text] [Related]
7. Shining a light on cell signaling in leukemia through proteomics: relevance for the clinic. Hoff FW; Hu CW; Qutub AA; de Bont ESJM; Horton TM; Kornblau SM Expert Rev Proteomics; 2018 Jul; 15(7):613-622. PubMed ID: 29898608 [TBL] [Abstract][Full Text] [Related]
8. Targeted therapy in acute myeloid leukemia: current status and new insights from a proteomic perspective. van Dijk AD; de Bont ESJM; Kornblau SM Expert Rev Proteomics; 2020 Jan; 17(1):1-10. PubMed ID: 31945303 [No Abstract] [Full Text] [Related]
9. Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemia. van Dijk AD; Hoff FW; Qiu YH; Chandra J; Jabbour E; de Bont ESJM; Horton TM; Kornblau SM Clin Epigenetics; 2021 Jan; 13(1):21. PubMed ID: 33509276 [TBL] [Abstract][Full Text] [Related]
10. Quantification of Biomarker Proteins Using Reverse-Phase Protein Arrays. Yamada T Proteomics Clin Appl; 2020 Jul; 14(4):e1900120. PubMed ID: 32109350 [TBL] [Abstract][Full Text] [Related]
11. Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse. Hoff FW; Hu CW; Qutub AA; Qiu Y; Hornbaker MJ; Bueso-Ramos C; Abbas HA; Post SM; de Bont ESJM; Kornblau SM Proteomics Clin Appl; 2019 Jul; 13(4):e1800133. PubMed ID: 30650251 [TBL] [Abstract][Full Text] [Related]
12. Construction of protein profile classification model and screening of proteomic signature of acute leukemia. Xu Y; Zhuo J; Duan Y; Shi B; Chen X; Zhang X; Xiao L; Lou J; Huang R; Zhang Q; Du X; Li M; Wang D; Shi D Int J Clin Exp Pathol; 2014; 7(9):5569-81. PubMed ID: 25337199 [TBL] [Abstract][Full Text] [Related]
13. Reverse phase protein arrays in signaling pathways: a data integration perspective. Creighton CJ; Huang S Drug Des Devel Ther; 2015; 9():3519-27. PubMed ID: 26185419 [TBL] [Abstract][Full Text] [Related]
14. Reverse phase protein arrays: mapping the path towards personalized medicine. Gallagher RI; Espina V Mol Diagn Ther; 2014 Dec; 18(6):619-30. PubMed ID: 25358623 [TBL] [Abstract][Full Text] [Related]
15. Reverse Phase Proteomic Array Profiling of Asparagine Synthetase Expression in Newly Diagnosed Acute Myeloid Leukemia. Narayanan N; Marvin-Peek J; Abouelnaaj MK; Majid D; Wang B; Brown BD; Qiu Y; Kornblau SM; Abbas HA J Proteome Res; 2024 Jul; 23(7):2495-2504. PubMed ID: 38829961 [TBL] [Abstract][Full Text] [Related]
16. Analysis of Reverse Phase Protein Array Data: From Experimental Design towards Targeted Biomarker Discovery. Wachter A; Bernhardt S; Beissbarth T; Korf U Microarrays (Basel); 2015 Nov; 4(4):520-39. PubMed ID: 27600238 [TBL] [Abstract][Full Text] [Related]
17. Reverse Phase Protein Arrays for Compound Profiling. Moerke N; Fallahi-Sichani M Curr Protoc Chem Biol; 2016 Sep; 8(3):179-196. PubMed ID: 27622568 [TBL] [Abstract][Full Text] [Related]
18. Proteomic approaches for untangling pharmacological targets in acute myelogenous leukemia. Reikvam H; Hemsing AL; Hernandez-Valladares M; Birkeland E Expert Rev Proteomics; 2022 Feb; 19(2):73-76. PubMed ID: 35436165 [No Abstract] [Full Text] [Related]
19. Subtyping of breast cancer using reverse phase protein arrays. Sonntag J; Schlüter K; Bernhardt S; Korf U Expert Rev Proteomics; 2014 Dec; 11(6):757-70. PubMed ID: 25400094 [TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of proteomic profiling in Hoff FW; Van Dijk AD; Qiu Y; Hu CW; Ries RE; Ligeralde A; Jenkins GN; Gerbing RB; Gamis AS; Aplenc R; Kolb EA; Alonzo TA; Meshinchi S; Qutub AA; De Bont ESJM; Horton TM; Kornblau SM Haematologica; 2022 Oct; 107(10):2329-2343. PubMed ID: 35021602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]